Edap Tms Talks Surging HIFU Demand, Focal One i Launch and Reimbursement Tailwinds at Conference

EDAP management highlighted what it sees as a growing global opportunity for therapeutic ultrasound in urology, emphasizing the company’s Focal One robotic high-intensity focused ultrasound (HIFU) ...
MedPage Today

Non-Ablative Treatment for BPH/LUTS Achieves Rapid, Sustained Improvements

A non-ablative treatment for benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) achieved durable ...
bpHope.com

‘BrainStorm’ Documentary Explores Life Across the Bipolar Spectrum

Filmmakers Sara Schley and Bonnie Waltch discuss 'BrainStorm' and its exploration of bipolar stigma, diagnosis, lived experience, and hope.
Pharmabiz

Prodeon Medical’s Urocross Expander System receives US FDA 510(k) clearance for treating urinary symptoms associated with benign prostatic hyperplasia

Prodeon Medical’s Urocross Expander System receives US FDA 510(k) clearance for treating urinary symptoms associated with benign prostatic hyperplasia: Sunnyvale, California Thu ...
The Print

Capitol Hospital Urology Experts Advise: Don’t Ignore the Signs of Prostate Enlargement

As men age, their bodies go through many natural changes. One such change, often less spoken about, is the enlargement of the ...
MedTech Intelligence

Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia

The Urocross Expander System is designed to remodel the obstructing prostatic lobes during the six-month indwell time and is intentionally retrieved, leaving no permanent foreign material behind.

Prodeon Medical Receives FDA 510(k) Clearance for the Urocross(R) Expander System, a Novel Non-Permanent Retrievable Implant for Treating Urinary Symptoms Associated with ...

Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced it has received U.S. Food and Drug Administration (FDA ...
Medical Device Network

Prodeon Medical’s BPH implant gains FDA clearance

In data supporting FDA approval, 48.1% implanted with Prodeon’s Urocross saw International Prostate Symptom Score ...

Prodeon Medical Receives FDA 510(k) Clearance for the Urocross® Expander System, a Novel Non-Permanent Retrievable Implant for Treating Urinary Symptoms Associated with Benign ...

Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced it has received U.S. Food and Drug Administration (FDA ...
Newspoint on MSN

Enlarged prostate symptoms: These 5 signs after the age of 40 are a warning sign for men, as the prostate enlarges

Prostate Enlargement Treatment: Prostate problems are increasing rapidly in men. Let us tell you which major signs should not be ignored after 40 and when should you consult a doctor? What are the ...
MassDevice

Procept BioRobotics announces international Hydros robot launch

Procept BioRobotics today announced the international rollout of its next-generation Hydros robotic system for Aquablation therapy.

PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy

PROCEPT BioRobotics (Nasdaq: PRCT), today announced the international expansion of the HYDROS Robotic System, the company’s next-generation platform for delivering Aquablation therapy to treat benign ...